nodes	percent_of_prediction	percent_of_DWPC	metapath
Hyoscyamine—Loss of libido—Lovastatin—atherosclerosis	0.0166	0.0232	CcSEcCtD
Hyoscyamine—Loss of libido—Simvastatin—atherosclerosis	0.0156	0.0217	CcSEcCtD
Hyoscyamine—Loss of libido—Pravastatin—atherosclerosis	0.0141	0.0197	CcSEcCtD
Hyoscyamine—Blood disorder—Rosuvastatin—atherosclerosis	0.0108	0.0152	CcSEcCtD
Hyoscyamine—Heartburn—Niacin—atherosclerosis	0.00958	0.0134	CcSEcCtD
Hyoscyamine—Heartburn—Pravastatin—atherosclerosis	0.00943	0.0132	CcSEcCtD
Hyoscyamine—Laryngitis—Niacin—atherosclerosis	0.00915	0.0128	CcSEcCtD
Hyoscyamine—Laryngospasm—Niacin—atherosclerosis	0.00883	0.0123	CcSEcCtD
Hyoscyamine—Feeling hot—Niacin—atherosclerosis	0.0084	0.0117	CcSEcCtD
Hyoscyamine—Gastrooesophageal reflux disease—Ezetimibe—atherosclerosis	0.00834	0.0117	CcSEcCtD
Hyoscyamine—Hypertonia—Rosuvastatin—atherosclerosis	0.00794	0.0111	CcSEcCtD
Hyoscyamine—Amnesia—Rosuvastatin—atherosclerosis	0.007	0.00979	CcSEcCtD
Hyoscyamine—Muscle twitching—Niacin—atherosclerosis	0.00672	0.00939	CcSEcCtD
Hyoscyamine—Dermatitis contact—Niacin—atherosclerosis	0.00652	0.00911	CcSEcCtD
Hyoscyamine—Skin exfoliation—Niacin—atherosclerosis	0.0063	0.0088	CcSEcCtD
Hyoscyamine—Rash maculo-papular—Niacin—atherosclerosis	0.00599	0.00838	CcSEcCtD
Hyoscyamine—Amnesia—Lovastatin—atherosclerosis	0.00593	0.00829	CcSEcCtD
Hyoscyamine—Swelling—Simvastatin—atherosclerosis	0.00591	0.00826	CcSEcCtD
Hyoscyamine—Amnesia—Ezetimibe—atherosclerosis	0.00582	0.00813	CcSEcCtD
Hyoscyamine—Eczema—Simvastatin—atherosclerosis	0.0058	0.00811	CcSEcCtD
Hyoscyamine—Hypertonia—Niacin—atherosclerosis	0.00578	0.00808	CcSEcCtD
Hyoscyamine—Amnesia—Simvastatin—atherosclerosis	0.00555	0.00776	CcSEcCtD
Hyoscyamine—Atrial fibrillation—Simvastatin—atherosclerosis	0.0055	0.00769	CcSEcCtD
Hyoscyamine—Eczema—Niacin—atherosclerosis	0.00533	0.00745	CcSEcCtD
Hyoscyamine—Depression—Rosuvastatin—atherosclerosis	0.00505	0.00706	CcSEcCtD
Hyoscyamine—Atrial fibrillation—Niacin—atherosclerosis	0.00505	0.00706	CcSEcCtD
Hyoscyamine—Amnesia—Pravastatin—atherosclerosis	0.00502	0.00701	CcSEcCtD
Hyoscyamine—Urinary retention—Niacin—atherosclerosis	0.00455	0.00636	CcSEcCtD
Hyoscyamine—Erectile dysfunction—Lovastatin—atherosclerosis	0.00444	0.0062	CcSEcCtD
Hyoscyamine—Dry skin—Niacin—atherosclerosis	0.00439	0.00613	CcSEcCtD
Hyoscyamine—Erectile dysfunction—Ezetimibe—atherosclerosis	0.00435	0.00608	CcSEcCtD
Hyoscyamine—Dry skin—Pravastatin—atherosclerosis	0.00432	0.00604	CcSEcCtD
Hyoscyamine—Abdominal distension—Niacin—atherosclerosis	0.00417	0.00582	CcSEcCtD
Hyoscyamine—Erectile dysfunction—Simvastatin—atherosclerosis	0.00415	0.0058	CcSEcCtD
Hyoscyamine—Dysphagia—Niacin—atherosclerosis	0.00414	0.00578	CcSEcCtD
Hyoscyamine—Abdominal distension—Pravastatin—atherosclerosis	0.0041	0.00573	CcSEcCtD
Hyoscyamine—Arrhythmia—Rosuvastatin—atherosclerosis	0.00406	0.00568	CcSEcCtD
Hyoscyamine—Angina pectoris—Niacin—atherosclerosis	0.00403	0.00563	CcSEcCtD
Hyoscyamine—Depression—Simvastatin—atherosclerosis	0.00401	0.0056	CcSEcCtD
Hyoscyamine—Mental disorder—Rosuvastatin—atherosclerosis	0.00399	0.00557	CcSEcCtD
Hyoscyamine—Angina pectoris—Pravastatin—atherosclerosis	0.00397	0.00555	CcSEcCtD
Hyoscyamine—Erectile dysfunction—Niacin—atherosclerosis	0.00381	0.00533	CcSEcCtD
Hyoscyamine—Dysuria—Pravastatin—atherosclerosis	0.00381	0.00532	CcSEcCtD
Hyoscyamine—Erectile dysfunction—Pravastatin—atherosclerosis	0.00375	0.00524	CcSEcCtD
Hyoscyamine—Depression—Pravastatin—atherosclerosis	0.00362	0.00506	CcSEcCtD
Hyoscyamine—Angioedema—Rosuvastatin—atherosclerosis	0.00362	0.00506	CcSEcCtD
Hyoscyamine—Acute coronary syndrome—Pravastatin—atherosclerosis	0.00358	0.00501	CcSEcCtD
Hyoscyamine—Flushing—Lovastatin—atherosclerosis	0.00358	0.005	CcSEcCtD
Hyoscyamine—Myocardial infarction—Pravastatin—atherosclerosis	0.00356	0.00498	CcSEcCtD
Hyoscyamine—Sweating—Niacin—atherosclerosis	0.00354	0.00494	CcSEcCtD
Hyoscyamine—Flushing—Ezetimibe—atherosclerosis	0.00351	0.00491	CcSEcCtD
Hyoscyamine—Flushing—Simvastatin—atherosclerosis	0.00335	0.00468	CcSEcCtD
Hyoscyamine—Mental disorder—Ezetimibe—atherosclerosis	0.00331	0.00463	CcSEcCtD
Hyoscyamine—Erythema—Ezetimibe—atherosclerosis	0.00329	0.0046	CcSEcCtD
Hyoscyamine—Dysgeusia—Lovastatin—atherosclerosis	0.00329	0.00459	CcSEcCtD
Hyoscyamine—Confusional state—Rosuvastatin—atherosclerosis	0.00326	0.00456	CcSEcCtD
Hyoscyamine—Vision blurred—Lovastatin—atherosclerosis	0.00316	0.00442	CcSEcCtD
Hyoscyamine—Mental disorder—Simvastatin—atherosclerosis	0.00316	0.00442	CcSEcCtD
Hyoscyamine—Erythema—Simvastatin—atherosclerosis	0.00314	0.00439	CcSEcCtD
Hyoscyamine—Dysgeusia—Simvastatin—atherosclerosis	0.00307	0.0043	CcSEcCtD
Hyoscyamine—Flushing—Niacin—atherosclerosis	0.00307	0.0043	CcSEcCtD
Hyoscyamine—Angioedema—Lovastatin—atherosclerosis	0.00307	0.00429	CcSEcCtD
Hyoscyamine—Flushing—Pravastatin—atherosclerosis	0.00303	0.00423	CcSEcCtD
Hyoscyamine—Vertigo—Lovastatin—atherosclerosis	0.00302	0.00422	CcSEcCtD
Hyoscyamine—Angioedema—Ezetimibe—atherosclerosis	0.00301	0.00421	CcSEcCtD
Hyoscyamine—Benzatropine—HRH1—atherosclerosis	0.00297	1	CrCbGaD
Hyoscyamine—Vision blurred—Simvastatin—atherosclerosis	0.00296	0.00414	CcSEcCtD
Hyoscyamine—Arrhythmia—Niacin—atherosclerosis	0.00296	0.00414	CcSEcCtD
Hyoscyamine—Insomnia—Rosuvastatin—atherosclerosis	0.00292	0.00409	CcSEcCtD
Hyoscyamine—Arrhythmia—Pravastatin—atherosclerosis	0.00291	0.00407	CcSEcCtD
Hyoscyamine—Palpitations—Ezetimibe—atherosclerosis	0.00291	0.00407	CcSEcCtD
Hyoscyamine—Erythema—Niacin—atherosclerosis	0.00288	0.00403	CcSEcCtD
Hyoscyamine—Angioedema—Simvastatin—atherosclerosis	0.00287	0.00401	CcSEcCtD
Hyoscyamine—Chest pain—Lovastatin—atherosclerosis	0.00286	0.00399	CcSEcCtD
Hyoscyamine—Anxiety—Lovastatin—atherosclerosis	0.00285	0.00398	CcSEcCtD
Hyoscyamine—Dyspepsia—Rosuvastatin—atherosclerosis	0.00285	0.00398	CcSEcCtD
Hyoscyamine—Tension—Niacin—atherosclerosis	0.00283	0.00395	CcSEcCtD
Hyoscyamine—Vertigo—Simvastatin—atherosclerosis	0.00282	0.00394	CcSEcCtD
Hyoscyamine—Chest pain—Ezetimibe—atherosclerosis	0.0028	0.00392	CcSEcCtD
Hyoscyamine—Nervousness—Niacin—atherosclerosis	0.0028	0.00391	CcSEcCtD
Hyoscyamine—Dry mouth—Lovastatin—atherosclerosis	0.00279	0.00391	CcSEcCtD
Hyoscyamine—Tension—Pravastatin—atherosclerosis	0.00279	0.00389	CcSEcCtD
Hyoscyamine—Dysgeusia—Pravastatin—atherosclerosis	0.00278	0.00389	CcSEcCtD
Hyoscyamine—Pain—Rosuvastatin—atherosclerosis	0.00276	0.00386	CcSEcCtD
Hyoscyamine—Constipation—Rosuvastatin—atherosclerosis	0.00276	0.00386	CcSEcCtD
Hyoscyamine—Confusional state—Lovastatin—atherosclerosis	0.00276	0.00386	CcSEcCtD
Hyoscyamine—Nervousness—Pravastatin—atherosclerosis	0.00276	0.00385	CcSEcCtD
Hyoscyamine—Dry mouth—Ezetimibe—atherosclerosis	0.00274	0.00383	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Lovastatin—atherosclerosis	0.00274	0.00383	CcSEcCtD
Hyoscyamine—Vision blurred—Niacin—atherosclerosis	0.00272	0.0038	CcSEcCtD
Hyoscyamine—Confusional state—Ezetimibe—atherosclerosis	0.00271	0.00379	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Ezetimibe—atherosclerosis	0.00269	0.00376	CcSEcCtD
Hyoscyamine—Vision blurred—Pravastatin—atherosclerosis	0.00268	0.00374	CcSEcCtD
Hyoscyamine—Chest pain—Simvastatin—atherosclerosis	0.00267	0.00374	CcSEcCtD
Hyoscyamine—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00266	0.00372	CcSEcCtD
Hyoscyamine—Anxiety—Simvastatin—atherosclerosis	0.00266	0.00372	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00264	0.0037	CcSEcCtD
Hyoscyamine—Angioedema—Niacin—atherosclerosis	0.00263	0.00368	CcSEcCtD
Hyoscyamine—Angioedema—Pravastatin—atherosclerosis	0.00259	0.00363	CcSEcCtD
Hyoscyamine—Vertigo—Niacin—atherosclerosis	0.00259	0.00362	CcSEcCtD
Hyoscyamine—Syncope—Niacin—atherosclerosis	0.00259	0.00361	CcSEcCtD
Hyoscyamine—Confusional state—Simvastatin—atherosclerosis	0.00258	0.00361	CcSEcCtD
Hyoscyamine—Urticaria—Rosuvastatin—atherosclerosis	0.00257	0.00359	CcSEcCtD
Hyoscyamine—Oedema—Simvastatin—atherosclerosis	0.00256	0.00358	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Simvastatin—atherosclerosis	0.00256	0.00358	CcSEcCtD
Hyoscyamine—Abdominal pain—Rosuvastatin—atherosclerosis	0.00256	0.00357	CcSEcCtD
Hyoscyamine—Vertigo—Pravastatin—atherosclerosis	0.00255	0.00356	CcSEcCtD
Hyoscyamine—Palpitations—Niacin—atherosclerosis	0.00255	0.00356	CcSEcCtD
Hyoscyamine—Loss of consciousness—Niacin—atherosclerosis	0.00253	0.00354	CcSEcCtD
Hyoscyamine—Insomnia—Lovastatin—atherosclerosis	0.00248	0.00346	CcSEcCtD
Hyoscyamine—Dyspnoea—Lovastatin—atherosclerosis	0.00244	0.00341	CcSEcCtD
Hyoscyamine—Insomnia—Ezetimibe—atherosclerosis	0.00243	0.0034	CcSEcCtD
Hyoscyamine—Chest pain—Pravastatin—atherosclerosis	0.00242	0.00338	CcSEcCtD
Hyoscyamine—Dyspepsia—Lovastatin—atherosclerosis	0.00241	0.00337	CcSEcCtD
Hyoscyamine—Anxiety—Pravastatin—atherosclerosis	0.00241	0.00337	CcSEcCtD
Hyoscyamine—Dry mouth—Niacin—atherosclerosis	0.0024	0.00336	CcSEcCtD
Hyoscyamine—Dyspnoea—Ezetimibe—atherosclerosis	0.0024	0.00335	CcSEcCtD
Hyoscyamine—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00238	0.00333	CcSEcCtD
Hyoscyamine—Dyspepsia—Ezetimibe—atherosclerosis	0.00237	0.00331	CcSEcCtD
Hyoscyamine—Fatigue—Lovastatin—atherosclerosis	0.00236	0.0033	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Niacin—atherosclerosis	0.00235	0.00329	CcSEcCtD
Hyoscyamine—Oedema—Niacin—atherosclerosis	0.00235	0.00329	CcSEcCtD
Hyoscyamine—Pain—Lovastatin—atherosclerosis	0.00234	0.00327	CcSEcCtD
Hyoscyamine—Constipation—Lovastatin—atherosclerosis	0.00234	0.00327	CcSEcCtD
Hyoscyamine—Confusional state—Pravastatin—atherosclerosis	0.00234	0.00327	CcSEcCtD
Hyoscyamine—Asthenia—Rosuvastatin—atherosclerosis	0.00232	0.00324	CcSEcCtD
Hyoscyamine—Insomnia—Simvastatin—atherosclerosis	0.00232	0.00324	CcSEcCtD
Hyoscyamine—Oedema—Pravastatin—atherosclerosis	0.00232	0.00324	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Pravastatin—atherosclerosis	0.00232	0.00324	CcSEcCtD
Hyoscyamine—Fatigue—Ezetimibe—atherosclerosis	0.00232	0.00324	CcSEcCtD
Hyoscyamine—Shock—Niacin—atherosclerosis	0.00231	0.00324	CcSEcCtD
Hyoscyamine—Constipation—Ezetimibe—atherosclerosis	0.0023	0.00321	CcSEcCtD
Hyoscyamine—Pain—Ezetimibe—atherosclerosis	0.0023	0.00321	CcSEcCtD
Hyoscyamine—Tachycardia—Niacin—atherosclerosis	0.0023	0.00321	CcSEcCtD
Hyoscyamine—Pruritus—Rosuvastatin—atherosclerosis	0.00229	0.0032	CcSEcCtD
Hyoscyamine—Dyspnoea—Simvastatin—atherosclerosis	0.00228	0.00319	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Niacin—atherosclerosis	0.00227	0.00318	CcSEcCtD
Hyoscyamine—Feeling abnormal—Lovastatin—atherosclerosis	0.00226	0.00316	CcSEcCtD
Hyoscyamine—Dyspepsia—Simvastatin—atherosclerosis	0.00226	0.00315	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00224	0.00313	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Pravastatin—atherosclerosis	0.00224	0.00313	CcSEcCtD
Hyoscyamine—Feeling abnormal—Ezetimibe—atherosclerosis	0.00221	0.0031	CcSEcCtD
Hyoscyamine—Diarrhoea—Rosuvastatin—atherosclerosis	0.00221	0.00309	CcSEcCtD
Hyoscyamine—Fatigue—Simvastatin—atherosclerosis	0.00221	0.00309	CcSEcCtD
Hyoscyamine—Hypotension—Niacin—atherosclerosis	0.0022	0.00307	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.0022	0.00307	CcSEcCtD
Hyoscyamine—Constipation—Simvastatin—atherosclerosis	0.00219	0.00306	CcSEcCtD
Hyoscyamine—Pain—Simvastatin—atherosclerosis	0.00219	0.00306	CcSEcCtD
Hyoscyamine—Urticaria—Lovastatin—atherosclerosis	0.00218	0.00304	CcSEcCtD
Hyoscyamine—Abdominal pain—Lovastatin—atherosclerosis	0.00217	0.00303	CcSEcCtD
Hyoscyamine—Body temperature increased—Lovastatin—atherosclerosis	0.00217	0.00303	CcSEcCtD
Hyoscyamine—Dizziness—Rosuvastatin—atherosclerosis	0.00214	0.00299	CcSEcCtD
Hyoscyamine—Urticaria—Ezetimibe—atherosclerosis	0.00213	0.00298	CcSEcCtD
Hyoscyamine—Insomnia—Niacin—atherosclerosis	0.00213	0.00297	CcSEcCtD
Hyoscyamine—Abdominal pain—Ezetimibe—atherosclerosis	0.00212	0.00297	CcSEcCtD
Hyoscyamine—Body temperature increased—Ezetimibe—atherosclerosis	0.00212	0.00297	CcSEcCtD
Hyoscyamine—Feeling abnormal—Simvastatin—atherosclerosis	0.00211	0.00295	CcSEcCtD
Hyoscyamine—Dyspnoea—Niacin—atherosclerosis	0.0021	0.00293	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Simvastatin—atherosclerosis	0.0021	0.00293	CcSEcCtD
Hyoscyamine—Insomnia—Pravastatin—atherosclerosis	0.0021	0.00293	CcSEcCtD
Hyoscyamine—Somnolence—Niacin—atherosclerosis	0.00209	0.00292	CcSEcCtD
Hyoscyamine—Dyspepsia—Niacin—atherosclerosis	0.00207	0.0029	CcSEcCtD
Hyoscyamine—Dyspnoea—Pravastatin—atherosclerosis	0.00207	0.00289	CcSEcCtD
Hyoscyamine—Dyspepsia—Pravastatin—atherosclerosis	0.00204	0.00285	CcSEcCtD
Hyoscyamine—Rash—Rosuvastatin—atherosclerosis	0.00204	0.00285	CcSEcCtD
Hyoscyamine—Dermatitis—Rosuvastatin—atherosclerosis	0.00204	0.00285	CcSEcCtD
Hyoscyamine—Urticaria—Simvastatin—atherosclerosis	0.00204	0.00285	CcSEcCtD
Hyoscyamine—Abdominal pain—Simvastatin—atherosclerosis	0.00203	0.00283	CcSEcCtD
Hyoscyamine—Body temperature increased—Simvastatin—atherosclerosis	0.00203	0.00283	CcSEcCtD
Hyoscyamine—Headache—Rosuvastatin—atherosclerosis	0.00203	0.00283	CcSEcCtD
Hyoscyamine—Hypersensitivity—Lovastatin—atherosclerosis	0.00202	0.00282	CcSEcCtD
Hyoscyamine—Pain—Niacin—atherosclerosis	0.00201	0.00281	CcSEcCtD
Hyoscyamine—Fatigue—Pravastatin—atherosclerosis	0.002	0.00279	CcSEcCtD
Hyoscyamine—Pain—Pravastatin—atherosclerosis	0.00198	0.00277	CcSEcCtD
Hyoscyamine—Constipation—Pravastatin—atherosclerosis	0.00198	0.00277	CcSEcCtD
Hyoscyamine—Hypersensitivity—Ezetimibe—atherosclerosis	0.00198	0.00277	CcSEcCtD
Hyoscyamine—Asthenia—Lovastatin—atherosclerosis	0.00197	0.00275	CcSEcCtD
Hyoscyamine—Pruritus—Lovastatin—atherosclerosis	0.00194	0.00271	CcSEcCtD
Hyoscyamine—Asthenia—Ezetimibe—atherosclerosis	0.00193	0.00269	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Niacin—atherosclerosis	0.00192	0.00269	CcSEcCtD
Hyoscyamine—Nausea—Rosuvastatin—atherosclerosis	0.00192	0.00268	CcSEcCtD
Hyoscyamine—Feeling abnormal—Pravastatin—atherosclerosis	0.00191	0.00267	CcSEcCtD
Hyoscyamine—Pruritus—Ezetimibe—atherosclerosis	0.0019	0.00266	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00189	0.00265	CcSEcCtD
Hyoscyamine—Hypersensitivity—Simvastatin—atherosclerosis	0.00189	0.00264	CcSEcCtD
Hyoscyamine—Diarrhoea—Lovastatin—atherosclerosis	0.00187	0.00262	CcSEcCtD
Hyoscyamine—Urticaria—Niacin—atherosclerosis	0.00187	0.00261	CcSEcCtD
Hyoscyamine—Abdominal pain—Niacin—atherosclerosis	0.00186	0.0026	CcSEcCtD
Hyoscyamine—Body temperature increased—Niacin—atherosclerosis	0.00186	0.0026	CcSEcCtD
Hyoscyamine—Urticaria—Pravastatin—atherosclerosis	0.00184	0.00257	CcSEcCtD
Hyoscyamine—Asthenia—Simvastatin—atherosclerosis	0.00184	0.00257	CcSEcCtD
Hyoscyamine—Diarrhoea—Ezetimibe—atherosclerosis	0.00184	0.00257	CcSEcCtD
Hyoscyamine—Abdominal pain—Pravastatin—atherosclerosis	0.00183	0.00256	CcSEcCtD
Hyoscyamine—Body temperature increased—Pravastatin—atherosclerosis	0.00183	0.00256	CcSEcCtD
Hyoscyamine—Pruritus—Simvastatin—atherosclerosis	0.00181	0.00253	CcSEcCtD
Hyoscyamine—Dizziness—Lovastatin—atherosclerosis	0.00181	0.00253	CcSEcCtD
Hyoscyamine—Dizziness—Ezetimibe—atherosclerosis	0.00178	0.00248	CcSEcCtD
Hyoscyamine—Diarrhoea—Simvastatin—atherosclerosis	0.00175	0.00245	CcSEcCtD
Hyoscyamine—Vomiting—Lovastatin—atherosclerosis	0.00174	0.00243	CcSEcCtD
Hyoscyamine—Hypersensitivity—Niacin—atherosclerosis	0.00173	0.00242	CcSEcCtD
Hyoscyamine—Rash—Lovastatin—atherosclerosis	0.00173	0.00241	CcSEcCtD
Hyoscyamine—Dermatitis—Lovastatin—atherosclerosis	0.00173	0.00241	CcSEcCtD
Hyoscyamine—Headache—Lovastatin—atherosclerosis	0.00172	0.0024	CcSEcCtD
Hyoscyamine—Vomiting—Ezetimibe—atherosclerosis	0.00171	0.00239	CcSEcCtD
Hyoscyamine—Hypersensitivity—Pravastatin—atherosclerosis	0.00171	0.00239	CcSEcCtD
Hyoscyamine—Dizziness—Simvastatin—atherosclerosis	0.00169	0.00237	CcSEcCtD
Hyoscyamine—Rash—Ezetimibe—atherosclerosis	0.00169	0.00237	CcSEcCtD
Hyoscyamine—Dermatitis—Ezetimibe—atherosclerosis	0.00169	0.00237	CcSEcCtD
Hyoscyamine—Asthenia—Niacin—atherosclerosis	0.00169	0.00236	CcSEcCtD
Hyoscyamine—Headache—Ezetimibe—atherosclerosis	0.00168	0.00235	CcSEcCtD
Hyoscyamine—Pruritus—Niacin—atherosclerosis	0.00166	0.00233	CcSEcCtD
Hyoscyamine—Asthenia—Pravastatin—atherosclerosis	0.00166	0.00232	CcSEcCtD
Hyoscyamine—Pruritus—Pravastatin—atherosclerosis	0.00164	0.00229	CcSEcCtD
Hyoscyamine—Vomiting—Simvastatin—atherosclerosis	0.00163	0.00228	CcSEcCtD
Hyoscyamine—Nausea—Lovastatin—atherosclerosis	0.00163	0.00227	CcSEcCtD
Hyoscyamine—Rash—Simvastatin—atherosclerosis	0.00162	0.00226	CcSEcCtD
Hyoscyamine—Dermatitis—Simvastatin—atherosclerosis	0.00161	0.00226	CcSEcCtD
Hyoscyamine—Diarrhoea—Niacin—atherosclerosis	0.00161	0.00225	CcSEcCtD
Hyoscyamine—Headache—Simvastatin—atherosclerosis	0.00161	0.00224	CcSEcCtD
Hyoscyamine—Nausea—Ezetimibe—atherosclerosis	0.0016	0.00223	CcSEcCtD
Hyoscyamine—Diarrhoea—Pravastatin—atherosclerosis	0.00159	0.00222	CcSEcCtD
Hyoscyamine—Dizziness—Niacin—atherosclerosis	0.00156	0.00217	CcSEcCtD
Hyoscyamine—Dizziness—Pravastatin—atherosclerosis	0.00153	0.00214	CcSEcCtD
Hyoscyamine—Nausea—Simvastatin—atherosclerosis	0.00152	0.00213	CcSEcCtD
Hyoscyamine—Vomiting—Niacin—atherosclerosis	0.0015	0.00209	CcSEcCtD
Hyoscyamine—Rash—Niacin—atherosclerosis	0.00148	0.00207	CcSEcCtD
Hyoscyamine—Dermatitis—Niacin—atherosclerosis	0.00148	0.00207	CcSEcCtD
Hyoscyamine—Headache—Niacin—atherosclerosis	0.00147	0.00206	CcSEcCtD
Hyoscyamine—Vomiting—Pravastatin—atherosclerosis	0.00147	0.00206	CcSEcCtD
Hyoscyamine—Rash—Pravastatin—atherosclerosis	0.00146	0.00204	CcSEcCtD
Hyoscyamine—Dermatitis—Pravastatin—atherosclerosis	0.00146	0.00204	CcSEcCtD
Hyoscyamine—Headache—Pravastatin—atherosclerosis	0.00145	0.00203	CcSEcCtD
Hyoscyamine—Nausea—Niacin—atherosclerosis	0.0014	0.00195	CcSEcCtD
Hyoscyamine—Nausea—Pravastatin—atherosclerosis	0.00138	0.00192	CcSEcCtD
Hyoscyamine—CHRM4—Signaling Pathways—PLG—atherosclerosis	0.000134	0.000476	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—EDN1—atherosclerosis	0.000133	0.000473	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—EDN1—atherosclerosis	0.000133	0.000471	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—CCL5—atherosclerosis	0.000132	0.000469	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—CCL5—atherosclerosis	0.000132	0.000468	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—EDN1—atherosclerosis	0.000131	0.000467	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—CCL5—atherosclerosis	0.00013	0.000463	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—HMGCR—atherosclerosis	0.00013	0.000462	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—SOCS3—atherosclerosis	0.000127	0.000451	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—PRKCG—atherosclerosis	0.000126	0.000446	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—PRKCG—atherosclerosis	0.000125	0.000445	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—VWF—atherosclerosis	0.000125	0.000444	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—VWF—atherosclerosis	0.000125	0.000443	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—APOC3—atherosclerosis	0.000124	0.000441	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—PRKCG—atherosclerosis	0.000124	0.00044	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—APOC3—atherosclerosis	0.000124	0.00044	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—LDLR—atherosclerosis	0.000124	0.000439	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—VWF—atherosclerosis	0.000124	0.000439	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—LDLR—atherosclerosis	0.000123	0.000437	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—APOC3—atherosclerosis	0.000123	0.000436	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—MMP3—atherosclerosis	0.000123	0.000436	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—IGF2—atherosclerosis	0.000122	0.000434	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—LDLR—atherosclerosis	0.000122	0.000433	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—AGT—atherosclerosis	0.000122	0.000432	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—AGT—atherosclerosis	0.000121	0.000431	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CCL3—atherosclerosis	0.000121	0.000429	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CCL3—atherosclerosis	0.00012	0.000427	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—AGT—atherosclerosis	0.00012	0.000427	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CCL3—atherosclerosis	0.000119	0.000423	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—APOB—atherosclerosis	0.000119	0.000421	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR downstream signaling—CXCL8—atherosclerosis	0.000118	0.000417	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—EDN1—atherosclerosis	0.000117	0.000414	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—ABCA1—atherosclerosis	0.000116	0.000412	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CCL5—atherosclerosis	0.000116	0.000411	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—NCF1—atherosclerosis	0.000116	0.00041	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—NCF1—atherosclerosis	0.000115	0.000409	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—NCF1—atherosclerosis	0.000114	0.000405	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—LPL—atherosclerosis	0.000113	0.000402	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—F2—atherosclerosis	0.000113	0.000399	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—F2—atherosclerosis	0.000112	0.000398	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—F2—atherosclerosis	0.000111	0.000394	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—AGT—atherosclerosis	0.000111	0.000393	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—AGT—atherosclerosis	0.00011	0.000391	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—PRKCG—atherosclerosis	0.00011	0.000391	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—EDNRA—atherosclerosis	0.000109	0.000388	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CCR2—atherosclerosis	0.000109	0.000388	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—AGT—atherosclerosis	0.000109	0.000388	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CCR2—atherosclerosis	0.000109	0.000386	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—EDNRA—atherosclerosis	0.000109	0.000386	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CYBA—atherosclerosis	0.000109	0.000386	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CYBA—atherosclerosis	0.000108	0.000385	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—EDNRA—atherosclerosis	0.000108	0.000383	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CCR2—atherosclerosis	0.000108	0.000383	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000108	0.000382	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000107	0.000381	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CYBA—atherosclerosis	0.000107	0.000381	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—SPP1—atherosclerosis	0.000107	0.000381	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—CXCL8—atherosclerosis	0.000107	0.000379	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—GHRL—atherosclerosis	0.000106	0.000378	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—PARP1—atherosclerosis	0.000106	0.000378	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—PLAT—atherosclerosis	0.000106	0.000378	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000106	0.000377	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—GHRL—atherosclerosis	0.000106	0.000377	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—PARP1—atherosclerosis	0.000106	0.000377	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—PLAT—atherosclerosis	0.000106	0.000377	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—GHRL—atherosclerosis	0.000105	0.000373	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PARP1—atherosclerosis	0.000105	0.000373	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PLAT—atherosclerosis	0.000105	0.000373	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—F2—atherosclerosis	0.000102	0.000363	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—F2—atherosclerosis	0.000102	0.000362	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—F2—atherosclerosis	0.000101	0.000358	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—HMOX1—atherosclerosis	9.95e-05	0.000353	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—PDGFB—atherosclerosis	9.92e-05	0.000352	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—PIK3CG—atherosclerosis	9.78e-05	0.000347	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—PIK3CG—atherosclerosis	9.75e-05	0.000346	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—AGT—atherosclerosis	9.69e-05	0.000344	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—PIK3CG—atherosclerosis	9.65e-05	0.000343	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—APOB—atherosclerosis	9.53e-05	0.000338	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—LEP—atherosclerosis	9.49e-05	0.000337	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—APOE—atherosclerosis	9.49e-05	0.000337	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CAV1—atherosclerosis	9.4e-05	0.000334	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—APOA1—atherosclerosis	9.38e-05	0.000333	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—KNG1—atherosclerosis	9.34e-05	0.000332	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—KNG1—atherosclerosis	9.31e-05	0.00033	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—AGTR1—atherosclerosis	9.28e-05	0.00033	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—GSTM1—atherosclerosis	9.27e-05	0.000329	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—AGTR1—atherosclerosis	9.25e-05	0.000329	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—KNG1—atherosclerosis	9.22e-05	0.000327	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—AGTR1—atherosclerosis	9.16e-05	0.000325	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—CCL2—atherosclerosis	9.11e-05	0.000323	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—LPL—atherosclerosis	9.1e-05	0.000323	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—CCL2—atherosclerosis	9.08e-05	0.000322	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—ESR1—atherosclerosis	9.06e-05	0.000322	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—PLG—atherosclerosis	9.05e-05	0.000321	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—PLG—atherosclerosis	9.02e-05	0.00032	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—CCL2—atherosclerosis	8.99e-05	0.000319	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—F2—atherosclerosis	8.95e-05	0.000318	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PLG—atherosclerosis	8.93e-05	0.000317	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—GPX1—atherosclerosis	8.88e-05	0.000315	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—CD36—atherosclerosis	8.65e-05	0.000307	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—SOCS3—atherosclerosis	8.57e-05	0.000304	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—PIK3CG—atherosclerosis	8.57e-05	0.000304	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—SOCS3—atherosclerosis	8.54e-05	0.000303	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—SOCS3—atherosclerosis	8.46e-05	0.0003	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—MMP3—atherosclerosis	8.27e-05	0.000294	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—MMP3—atherosclerosis	8.25e-05	0.000293	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—IGF2—atherosclerosis	8.24e-05	0.000292	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—IGF2—atherosclerosis	8.21e-05	0.000292	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—MAPK3—atherosclerosis	8.2e-05	0.000291	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—MTHFR—atherosclerosis	8.2e-05	0.000291	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—MMP3—atherosclerosis	8.17e-05	0.00029	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—IGF2—atherosclerosis	8.13e-05	0.000289	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—INS—atherosclerosis	8.11e-05	0.000288	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—PPARA—atherosclerosis	8.04e-05	0.000285	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—APOB—atherosclerosis	8e-05	0.000284	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CCL2—atherosclerosis	7.98e-05	0.000283	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—APOB—atherosclerosis	7.97e-05	0.000283	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—CXCL8—atherosclerosis	7.93e-05	0.000281	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—CXCL8—atherosclerosis	7.9e-05	0.000281	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—APOB—atherosclerosis	7.89e-05	0.00028	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—EDN1—atherosclerosis	7.87e-05	0.000279	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—EDN1—atherosclerosis	7.84e-05	0.000279	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—IGF1—atherosclerosis	7.84e-05	0.000278	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—CXCL8—atherosclerosis	7.83e-05	0.000278	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CCL5—atherosclerosis	7.81e-05	0.000277	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—AGT—atherosclerosis	7.79e-05	0.000276	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CCL5—atherosclerosis	7.78e-05	0.000276	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—EDN1—atherosclerosis	7.77e-05	0.000276	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CCL5—atherosclerosis	7.71e-05	0.000274	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—LPL—atherosclerosis	7.64e-05	0.000271	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—APOE—atherosclerosis	7.63e-05	0.000271	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—LPL—atherosclerosis	7.61e-05	0.00027	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—CAV1—atherosclerosis	7.56e-05	0.000268	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—APOA1—atherosclerosis	7.54e-05	0.000268	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—LPL—atherosclerosis	7.54e-05	0.000268	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—SERPINE1—atherosclerosis	7.45e-05	0.000264	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—PRKCG—atherosclerosis	7.42e-05	0.000264	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—PRKCG—atherosclerosis	7.4e-05	0.000263	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PRKCG—atherosclerosis	7.33e-05	0.00026	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—SPP1—atherosclerosis	7.23e-05	0.000257	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—SPP1—atherosclerosis	7.21e-05	0.000256	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—CXCL8—atherosclerosis	7.2e-05	0.000256	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—CXCL8—atherosclerosis	7.18e-05	0.000255	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—SPP1—atherosclerosis	7.14e-05	0.000253	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—NOS3—atherosclerosis	7.11e-05	0.000252	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—CXCL8—atherosclerosis	7.11e-05	0.000252	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—PIK3CG—atherosclerosis	6.89e-05	0.000244	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—PDGFB—atherosclerosis	6.69e-05	0.000238	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—PDGFB—atherosclerosis	6.67e-05	0.000237	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—PPARG—atherosclerosis	6.65e-05	0.000236	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PDGFB—atherosclerosis	6.6e-05	0.000235	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—AGT—atherosclerosis	6.53e-05	0.000232	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—INS—atherosclerosis	6.52e-05	0.000231	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—AGT—atherosclerosis	6.51e-05	0.000231	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—AGT—atherosclerosis	6.45e-05	0.000229	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—LEP—atherosclerosis	6.4e-05	0.000227	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—APOE—atherosclerosis	6.4e-05	0.000227	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—LEP—atherosclerosis	6.38e-05	0.000227	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—APOE—atherosclerosis	6.38e-05	0.000227	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CAV1—atherosclerosis	6.34e-05	0.000225	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—APOA1—atherosclerosis	6.33e-05	0.000225	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CAV1—atherosclerosis	6.32e-05	0.000224	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—LEP—atherosclerosis	6.32e-05	0.000224	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—APOE—atherosclerosis	6.32e-05	0.000224	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—CXCL8—atherosclerosis	6.31e-05	0.000224	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—APOA1—atherosclerosis	6.31e-05	0.000224	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CAV1—atherosclerosis	6.26e-05	0.000222	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—APOA1—atherosclerosis	6.25e-05	0.000222	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—ESR1—atherosclerosis	6.11e-05	0.000217	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR downstream signaling—AKT1—atherosclerosis	6.09e-05	0.000216	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—ESR1—atherosclerosis	6.09e-05	0.000216	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—F2—atherosclerosis	6.04e-05	0.000214	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—ESR1—atherosclerosis	6.03e-05	0.000214	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—F2—atherosclerosis	6.02e-05	0.000214	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—IL6—atherosclerosis	6e-05	0.000213	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—ALB—atherosclerosis	5.98e-05	0.000212	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—F2—atherosclerosis	5.96e-05	0.000212	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—PIK3CG—atherosclerosis	5.78e-05	0.000205	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—PIK3CG—atherosclerosis	5.76e-05	0.000204	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—NOS3—atherosclerosis	5.72e-05	0.000203	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—MMP9—atherosclerosis	5.7e-05	0.000203	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—PIK3CG—atherosclerosis	5.7e-05	0.000202	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—NFKB1—atherosclerosis	5.64e-05	0.0002	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—MAPK8—atherosclerosis	5.55e-05	0.000197	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—AKT1—atherosclerosis	5.53e-05	0.000196	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—MAPK3—atherosclerosis	5.53e-05	0.000196	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—MAPK3—atherosclerosis	5.51e-05	0.000196	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—INS—atherosclerosis	5.47e-05	0.000194	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—MAPK3—atherosclerosis	5.46e-05	0.000194	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—INS—atherosclerosis	5.45e-05	0.000194	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—INS—atherosclerosis	5.4e-05	0.000192	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CCL2—atherosclerosis	5.38e-05	0.000191	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CCL2—atherosclerosis	5.36e-05	0.00019	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CCL2—atherosclerosis	5.31e-05	0.000189	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—IGF1—atherosclerosis	5.29e-05	0.000188	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—IGF1—atherosclerosis	5.27e-05	0.000187	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—PTGS2—atherosclerosis	5.23e-05	0.000186	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—IGF1—atherosclerosis	5.22e-05	0.000185	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—VEGFA—atherosclerosis	5.12e-05	0.000182	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—STAT3—atherosclerosis	5.07e-05	0.00018	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—SERPINE1—atherosclerosis	5.02e-05	0.000178	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—SERPINE1—atherosclerosis	5.01e-05	0.000178	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—SERPINE1—atherosclerosis	4.96e-05	0.000176	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—MAPK3—atherosclerosis	4.85e-05	0.000172	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—NOS3—atherosclerosis	4.79e-05	0.00017	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—NOS3—atherosclerosis	4.78e-05	0.00017	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—NOS3—atherosclerosis	4.73e-05	0.000168	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—TGFB1—atherosclerosis	4.7e-05	0.000167	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—CXCL8—atherosclerosis	4.25e-05	0.000151	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—CXCL8—atherosclerosis	4.24e-05	0.000151	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—CXCL8—atherosclerosis	4.2e-05	0.000149	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—AKT1—atherosclerosis	4.11e-05	0.000146	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—AKT1—atherosclerosis	4.1e-05	0.000145	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—AKT1—atherosclerosis	4.06e-05	0.000144	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—IL6—atherosclerosis	4.04e-05	0.000144	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—IL6—atherosclerosis	4.03e-05	0.000143	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—IL6—atherosclerosis	3.99e-05	0.000142	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—MMP9—atherosclerosis	3.85e-05	0.000137	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—MMP9—atherosclerosis	3.83e-05	0.000136	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—NFKB1—atherosclerosis	3.81e-05	0.000135	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—MMP9—atherosclerosis	3.8e-05	0.000135	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—NFKB1—atherosclerosis	3.79e-05	0.000135	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—NFKB1—atherosclerosis	3.76e-05	0.000133	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—MAPK8—atherosclerosis	3.74e-05	0.000133	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—AKT1—atherosclerosis	3.73e-05	0.000132	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—MAPK8—atherosclerosis	3.73e-05	0.000132	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—AKT1—atherosclerosis	3.72e-05	0.000132	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—MAPK8—atherosclerosis	3.69e-05	0.000131	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—AKT1—atherosclerosis	3.68e-05	0.000131	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—IL6—atherosclerosis	3.54e-05	0.000126	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—VEGFA—atherosclerosis	3.45e-05	0.000123	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—VEGFA—atherosclerosis	3.44e-05	0.000122	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—STAT3—atherosclerosis	3.42e-05	0.000121	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—VEGFA—atherosclerosis	3.41e-05	0.000121	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—STAT3—atherosclerosis	3.41e-05	0.000121	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—STAT3—atherosclerosis	3.38e-05	0.00012	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—AKT1—atherosclerosis	3.27e-05	0.000116	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—MAPK3—atherosclerosis	3.27e-05	0.000116	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—MAPK3—atherosclerosis	3.26e-05	0.000116	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—MAPK3—atherosclerosis	3.23e-05	0.000115	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—TGFB1—atherosclerosis	3.17e-05	0.000113	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—TGFB1—atherosclerosis	3.16e-05	0.000112	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—TGFB1—atherosclerosis	3.13e-05	0.000111	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—AKT1—atherosclerosis	2.63e-05	9.33e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—IL6—atherosclerosis	2.39e-05	8.48e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—IL6—atherosclerosis	2.38e-05	8.46e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—IL6—atherosclerosis	2.36e-05	8.37e-05	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—AKT1—atherosclerosis	2.2e-05	7.83e-05	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—AKT1—atherosclerosis	2.2e-05	7.8e-05	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—AKT1—atherosclerosis	2.18e-05	7.72e-05	CbGpPWpGaD
